Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eun-Hee Shim

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
EMBO Reports|August 22, 2002
Targeted disruption of hsp70.1 sensitizes to osmotic stressEun-Hee Shim, Jong-Il Kim, Eui-Suk Bang, et al.
The Journal of Investigative Dermatology|July 11, 2020
Whole-Exome and Transcriptome Analysis of UV-Exposed Epidermis and Carcinoma In Situ Reveals Early Drivers of CarcinogenesisQi Zheng, Brian C Capell, Vishwas Parekh, et al.
Cancer Discovery|September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancerEun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2018
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal CancerSandeep Shelar, Eun-Hee Shim, Garrett J Brinkley, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
EMBO Reports|August 22, 2002
Targeted disruption of hsp70.1 sensitizes to osmotic stressEun-Hee Shim, Jong-Il Kim, Eui-Suk Bang, et al.
The Journal of Investigative Dermatology|July 11, 2020
Whole-Exome and Transcriptome Analysis of UV-Exposed Epidermis and Carcinoma In Situ Reveals Early Drivers of CarcinogenesisQi Zheng, Brian C Capell, Vishwas Parekh, et al.
Cancer Discovery|September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancerEun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2018
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal CancerSandeep Shelar, Eun-Hee Shim, Garrett J Brinkley, et al.
Pageof 2